Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,086,200 | -790,300 | -754,000 | -283,900 | -4,118,900 |
| Depreciation Amortization | 6,771,200 | 5,150,300 | 3,511,800 | 1,760,000 | 7,528,100 |
| Income taxes - deferred | -1,255,700 | -1,362,800 | -1,359,600 | -1,026,400 | -7,783,100 |
| Accounts receivable | -37,000 | 17,000 | 90,300 | 259,100 | -188,300 |
| Other Working Capital | -1,292,100 | 170,800 | 281,900 | 297,300 | 933,900 |
| Other Operating Activity | 6,539,900 | 956,500 | 928,100 | 452,200 | 9,707,300 |
| Operating Cash Flow | $5,640,100 | $4,141,500 | $2,698,500 | $1,458,300 | $6,079,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,259,300 | N/A | N/A | 4,889,500 | 15,153,300 |
| PPE Investments | -223,100 | -140,500 | -95,000 | -35,300 | -342,800 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -5,290,400 |
| Purchase Of Investment | -2,471,700 | -1,456,400 | -1,455,900 | -1,455,900 | -9,783,800 |
| Sale Of Investment | N/A | 6,201,300 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | 0 | 0 | N/A | -614,300 |
| Other Investing Activity | -466,000 | -466,000 | 5,185,300 | -466,000 | -614,300 |
| Investing Cash Flow | $3,098,500 | $4,138,400 | $3,634,400 | $2,932,300 | $-878,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,657,000 | 717,200 | 709,000 | 709,000 | 3,550,000 |
| Debt Repayment | -8,804,500 | -7,115,900 | -5,366,800 | -4,322,100 | -6,413,600 |
| Common Stock Issued | 102,400 | 98,200 | 69,200 | 35,500 | 183,400 |
| Common Stock Repurchased | -2,775,400 | -2,023,500 | -1,572,100 | -1,439,600 | -493,000 |
| Dividend Paid | -1,049,800 | -808,100 | -563,700 | -319,500 | -1,218,200 |
| Other Financing Activity | 190,200 | 209,800 | 234,000 | 129,000 | -737,800 |
| Financing Cash Flow | $-9,680,100 | $-8,922,300 | $-6,490,400 | $-5,207,700 | $-5,129,200 |
| Exchange Rate Effect | 4,700 | 13,100 | 15,000 | -5,300 | 21,400 |
| Beginning Cash Position | 1,817,200 | 1,817,200 | 1,817,200 | 1,817,200 | 1,724,000 |
| End Cash Position | 880,400 | 1,187,900 | 1,674,700 | 994,800 | 1,817,200 |
| Net Cash Flow | $-936,800 | $-629,300 | $-142,500 | $-822,400 | $93,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,640,100 | 4,141,500 | 2,698,500 | 1,458,300 | 6,079,000 |
| Capital Expenditure | -253,500 | -165,100 | -106,500 | -46,400 | -349,900 |
| Free Cash Flow | 5,386,600 | 3,976,400 | 2,592,000 | 1,411,900 | 5,729,100 |